Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy

20248 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Cancer

Volume 199, pp. 113561-113561

Field-Weighted Citation Impact: 2.05